HAIHONG CAI: Open Payments
NPI 1093895021 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 4 payments from 4 companies in 2025. Trend: 2023 $511 · 2024 $394 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $121 |
| Amgen Inc. | 1 | $121 |
| Janssen Biotech, Inc. | 1 | $91 |
Products named: Padcev, Trodelvy, VECTIBIX, RYBREVANT.
Industry payments across TX — which companies pay providers there.
